Volitionrx (VNRX) Free Cash Flow Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.61% |
| Sep 30, 2025 | 4.55% |
| Jun 30, 2025 | -3.42% |
| Mar 31, 2025 | 0.77% |
| Dec 31, 2024 | -17.61% |
| Sep 30, 2024 | -8.97% |
| Jun 30, 2024 | -20.58% |
| Mar 31, 2024 | -18.85% |
| Dec 31, 2023 | 32.33% |
| Sep 30, 2023 | -15.08% |
| Jun 30, 2023 | -21.30% |
| Mar 31, 2023 | -19.64% |
| Dec 31, 2022 | -9.95% |
| Sep 30, 2022 | -19.52% |
| Jun 30, 2022 | -16.49% |
| Mar 31, 2022 | 24.43% |
| Dec 31, 2021 | -12.51% |
| Sep 30, 2021 | -18.64% |
| Jun 30, 2021 | -18.58% |
| Mar 31, 2021 | -25.20% |
| Dec 31, 2020 | -14.00% |
| Sep 30, 2020 | -14.31% |
| Jun 30, 2020 | -22.08% |
| Mar 31, 2020 | -14.97% |
| Dec 31, 2019 | -19.64% |
| Sep 30, 2019 | -26.39% |
| Jun 30, 2019 | -14.67% |
| Mar 31, 2019 | -28.87% |
| Dec 31, 2018 | -37.70% |
| Sep 30, 2018 | -40.64% |
| Jun 30, 2018 | -23.08% |
| Mar 31, 2018 | -44.97% |
| Dec 31, 2017 | -53.47% |
| Sep 30, 2017 | -32.25% |
| Jun 30, 2017 | -38.94% |
| Mar 31, 2017 | -42.57% |
| Dec 31, 2016 | -31.80% |
| Sep 30, 2016 | -38.12% |
| Jun 30, 2016 | -52.44% |
| Mar 31, 2016 | -44.91% |